• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Shifamed

Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study

March 26, 2025 By Sean Whooley

Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million. The clinical-stage Shifamed portfolio company also recently completed enrollment for its U.S. SUPPORT I Early Feasibility Study (EFS) evaluating its percutaneous ventricular assist device (pVAD) for treating high-risk percutaneous coronary intervention (HRPCI). New investors Novo Holdings and Qatar […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Funding Roundup, Structural Heart Tagged With: Shifamed, supiramedical

Supira begins early feasability study for percutaneous ventricular assist device

November 21, 2024 By Sean Whooley

Supira Medical announced today that it began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD). The Shifamed portfolio company plans to evaluate the pVAD in patients undergoing high-risk percutaneous coronary intervention (HRPCI). Los Gatos, California-based Supira’s study looks at the safety and feasibility of the low-profile, high-flow device. […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Featured, Structural Heart Tagged With: Shifamed, supiramedical

FDA approves IDE for Akura Medical’s thrombectomy system

November 4, 2024 By Sean Whooley

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE). IDE means Akura can begin the QUADRA-PE study evaluating the thrombectomy system in patients with acute pulmonary embolism (PE). Dr. Sanjum Sethi (Columbia University Medical Center) and Dr. Ann Gage (Tristar Centennial Medical Center) serve as co-principal […]

Filed Under: Catheters, Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: Akura Medical, FDA, Shifamed

Shifamed’s Tioga Cardiovascular has first human cases with mitral valve replacement

October 23, 2024 By Sean Whooley

Tioga Cardiovascular, a Shifamed portfolio company, today announced the first-in-human implants for its Luna TMVR system. Luna, a 28 Fr. transcatheter mitral valve replacement (TMVR) system, features a unique valve and anchor design and utilizes nitinol. Los Gatos, California-based Tioga designed it to minimize patient exclusions and treat more patients with mitral regurgitation (MR). Dr. […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Implants, Replacement Heart Valves, Structural Heart Tagged With: nitinol, Shifamed, tiogamedical

Shifamed’s Adona Medical raises $33.5M

July 10, 2024 By Sean Whooley

Shifamed portfolio company Adona Medical announced today that it raised $33.5 million in a Series C financing round to support its adjustable heart shunt technology. Cormorant Asset Management and TCP Health Ventures led the financing. Excelstar Ventures, the PA MedTech VC Fund II, Unorthodox Ventures, AMED Ventures and other new and existing investors participated. (Our sibling site […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Funding Roundup, Structural Heart Tagged With: Adona Medical, Shifamed

Shifamed’s Laza Medical closes $36M Series A to support cardiac imaging tech

December 12, 2023 By Sean Whooley

Laza Medical, the latest Shifamed portfolio company, announced today that it closed a Series A financing worth $36 million. The latest positive news for a Shifamed company follows multiple milestones over the course of 2023. In June, Shifamed’s Adona Medical unveiled a next-generation heart failure management portfolio. In October, its Akura Medical unit raised $35 […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup, Health Technology, Imaging Tagged With: Laza Medical, Shifamed

Shifamed’s Akura Medical raises $35M for thrombectomy system

October 3, 2023 By Sean Whooley

Akura Medical, a Shifamed portfolio company, today announced the closing of a $35 million Series B financing round. Los Gatos, California-based Akura develops a differentiated approach to address the challenges of venous thromboembolism (VTE). The company earmarked the funds for supporting its FDA 510(k) clearance submission for the Akura mechanical thrombectomy platform. Other uses include […]

Filed Under: Blood Management, Business/Financial News, Funding Roundup, News Well, Vascular Tagged With: Akura Medical, Shifamed

Shifamed’s Adona Medical unveils next-gen heart failure management platform

July 10, 2023 By Sean Whooley

Shifamed portfolio company Adona Medical today announced the introduction of its next-generation heart failure platform. Brian Fahey, Adona Medical co-founder and CEO, unveiled the developing interatrial shunt technology in a presentation at the CSI Frankfurt 2023 conference. The Adona heart failure management platform features an adjustable interatrial shunt with integrated bi-atrial pressure monitoring. Its shunt […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Implants, Patient Monitoring, Structural Heart Tagged With: Adona Medical, Shifamed

Adona Medical raises $20.5M

September 2, 2020 By Sean Whooley

Shifamed portfolio company Adona Medical filed an SEC Form D to confirm the sale of nearly $20.5 million in equity. Campbell, Calif.-based Adona Medical is offering more than $24.8 million in equity in a new notice that had its first sale on Aug. 20, 2020. Adona Medical does not intend for the offering to last […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup Tagged With: Adona Medical, Shifamed

Atia Vision closes $20m Series D

May 19, 2020 By Sean Whooley

Shifamed spinout and intraocular lens maker Atia Vision announced today that it closed the second tranche of a $20 million Series D financing. Campbell, Calif.-based Atia Vision said in a news release that the funding round that was led by Cormorant Asset Management with participation from The Capital Partnership, AMED Ventures and Shangbay Capital. The […]

Filed Under: Business/Financial News, Funding Roundup, Optical/Ophthalmic Tagged With: Atia Vision, Shifamed

Myra Medical raises $3m seed round, lures ex-MVRx chief Chang as new CEO

October 10, 2019 By Sean Whooley

Newly formed Shifamed spinout Myra Medical said today that it closed a seed financing round worth $3.2 million and announced the appointment of Robert Chang as CEO. Campbell, Calif.-based Myra Medical was founded to produce surgical devices designed to enable maximum intraocular pressure reduction while reducing the risk of hypotony in patients with glaucoma. Proceeds […]

Filed Under: Featured, Funding Roundup, Optical/Ophthalmic Tagged With: Myra Medical, Shifamed

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy